May 21, 2020
May 21, 2020 – Here you will find some of new approval and lunched latest drug news. Please read some of news together here at our news section.
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Pharmaceutical News
May 20, 2020
May 20, 2020 The U.S. FDA has approved a new indication for Lynparza® (olaparib), manufactured by
AstraZeneca and Merck, to treat adult patients who have deleterious or suspected deleterious germline
May 15, 2020
May 15, 2020 – The U.S. FDA has approved a new indication for Pomalyst® (pomalidomide), manufactured
by Bristol Myers Squibb. It is indicated to treat AIDS-related Kaposi sarcoma
May 15, 2020
May 15, 2020 – The U.S. FDA has approved QinlockTM (ripretinib), manufactured by Deciphera
Pharmaceuticals, to treat adult patients who have advanced gastrointestinal
May 15, 2020
May 15, 2020 – The U.S. FDA has approved a new indication for Rubraca® (rucaparib), manufactured by
Clovis Oncology. Rubraca is now indicated to treat adult patients who have
May 11, 2020
May 11, 2020 – The U.S. FDA has approved a new indication for Lynparza® (olaparib), manufactured by
AstraZeneca. Lynparza is now indicated for use in combination with bevacizumab
May 8, 2020
May 7, 2020
May 7, 2020 – The U.S. FDA has approved TabrectaTM (capmatinib), manufactured by Novartis, to treat
adult patients who have metastatic non-small cell lung cancer (NSCLC) and